Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose CFZ533 in Rheumatoid Arthritis Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2014
This is a first-in-human study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single intravenous and subcutaneous doses of CFZ533 in healthy subjects and intravenous doses in rheumatoid arthritis patients.
Epistemonikos ID: 47a9597163377402c35c4f56f6e2e43905ff5a23
First added on: Mar 23, 2022